|
| 36795145 | Comparison of traditional outcome measures and self-assessed goal achievement in patients treated surgically for benign prostatic hyperplasia. | World J Urol | 2023 |
| 37628903 | Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types. | Int J Mol Sci | 2023 |
| 37117110 | Re: Fifteen-year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer. | Eur Urol | 2023 |
| 37410655 | Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice? | BJU Int | 2023 |
| 36648168 | Clinical performance of magnetic resonance imaging and biomarkers for prostate cancer diagnosis in men at high genetic risk. | BJU Int | 2023 |
| 34148861 | Risks and Benefits of Live Surgical Broadcast: A Systematic Review. | Eur Urol Focus | 2022 |
| 35383404 | Genomic sequencing in oncology: Considerations for integration in routine cancer care. | Eur J Cancer Care (Engl) | 2022 |
| 35626380 | The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters. | Diagnostics (Basel) | 2022 |
| 35711488 | The provision of prostate cancer patient information leaflets on an electronic tablet: A further step to paperless health-care provision. | Urol Ann | 2022 |
| 36263588 | Total pelvic exenteration surgery for loco-regionally advanced prostate cancer, is it justifiable? | BJU Int | 2022 |
| 35948708 | Spatially resolved clonal copy number alterations in benign and malignant tissue. | Nature | 2022 |
| 36115838 | Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones. | Nat Commun | 2022 |
| 35105477 | Re: Prostate Cancer Screening Using a Combination of Risk-prediction, MRI, and Targeted Prostate Biopsies (STHLM3-MRI): A Prospective, Population-based, Randomised, Open-label, Non-inferiority Trial. | Eur Urol | 2022 |
| 32540269 | Corrigendum to "Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_Score" [Eur Urol Focus 6 (2020) 458-62]. | Eur Urol Focus | 2021 |
| 35474657 | Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management. | BJUI Compass | 2021 |
| 33877364 | Zinc stable isotopes in urine as diagnostic for cancer of secretory organs. | Metallomics | 2021 |
| 33678516 | Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival. | Eur J Cancer | 2021 |
| 33590768 | Use of intraoperative fluorescence to enhance robot-assisted radical prostatectomy. | Future Oncol | 2021 |
| 33888445 | A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease. | Eur Urol Oncol | 2021 |
| 34638322 | Morphological Features Extracted by AI Associated with Spatial Transcriptomics in Prostate Cancer. | Cancers (Basel) | 2021 |
| 34155340 | Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer. | Br J Cancer | 2021 |
| 32229180 | Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration. | J Mol Diagn | 2020 |
| 31910313 | Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit - the 'Fry-Turnbull' effect. | BJU Int | 2020 |
| 31704280 | Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_Score. | Eur Urol Focus | 2020 |
| 31932659 | "TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now. | Prostate Cancer Prostatic Dis | 2020 |
| 32096894 | Anterior prostatectomy for the excision of bladder paraganglioma with prostatic invasion: a unique case of partial prostatectomy. | ANZ J Surg | 2020 |
| 32898981 | Editorial Comment. | J Urol | 2020 |
| 32641865 | Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model. | Br J Cancer | 2020 |
| 32444265 | Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis. | Eur Urol | 2020 |
| 32358562 | Harnessing the potential of multimodal radiotherapy in prostate cancer. | Nat Rev Urol | 2020 |
| 32301733 | Social Media Coverage of Scientific Articles Immediately After Publication Predicts Subsequent Citations - #SoME_Impact Score: Observational Analysis. | J Med Internet Res | 2020 |
| 30385048 | Genetic Reasons to Walk the Extra Mile to Prevent Prostate Cancer. | Eur Urol | 2019 |
| 30113754 | Prostatic capsular incision during radical prostatectomy has important oncological implications: a systematic review and meta-analysis. | BJU Int | 2019 |
| 30763461 | Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer: a Cochrane Review. | BJU Int | 2019 |
| 31104332 | Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy. | Prostate | 2019 |
| 28922689 | Changing face of robot-assisted radical prostatectomy in Melbourne over 12 years. | ANZ J Surg | 2018 |
| 30400059 | Neuroendocrine differentiation of prostate cancer leads to PSMA suppression. | Endocr Relat Cancer | 2018 |
| 30320443 | Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer. | Cochrane Database Syst Rev | 2018 |
| 29729848 | Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer. | EBioMedicine | 2018 |
| 29437778 | Identification of potential therapeutic targets in prostate cancer through a cross-species approach. | EMBO Mol Med | 2018 |
| 29458983 | First Report of Prostate-specific Membrane Antigen-targeted Immunotherapy in Prostate Cancer: The Future is Bright. | Eur Urol | 2018 |
| 29132711 | Orient Expression: Solving the Mystery of Asian Prostate Cancer? | Eur Urol | 2018 |
| 29195776 | Diagnostic Pathways for Screen-detected Prostate Cancer: The Plot Thickens. | Eur Urol | 2018 |
| 28753852 | DESNT: A Poor Prognosis Category of Human Prostate Cancer. | Eur Urol Focus | 2018 |
| 27579821 | Salvage robotic prostatectomy for radio recurrent prostate cancer: technical challenges and outcome analysis. | Minerva Urol Nefrol | 2017 |
| 28089303 | Practical Polling for Prostate Cancer: AR-V7-based Treatment Selection. | Eur Urol | 2017 |
| 28337414 | Pheochromocytoma with Negative Metanephrines: A Rarity and the Significance of Dopamine Secreting Tumors. | Urol Case Rep | 2017 |
| 28292578 | Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144]. | EBioMedicine | 2017 |
| 28238478 | Re: Diagnostic Accuracy of Multi-parametric MRI and TRUS Biopsy in Prostate Cancer (PROMIS): A Paired Validating Confirmatory Study. | Eur Urol | 2017 |
| 28286059 | Mining Human Prostate Cancer Datasets: The "camcAPP" Shiny App. | EBioMedicine | 2017 |